ALTA LIFE SCIENCES retweetledi
DeepUll seeks to replace 40-year-old sepsis Dx approach firstwordhealthtech.com/story/5665607 #sepsis #DeepUll #moleculardiagnostics #healthtech #advancedIVD #AI #innovation
English
ALTA LIFE SCIENCES
133 posts
ALTA LIFE SCIENCES retweetledi
Los fondos obtenidos por la 'start up' fundada en 2020 por Jordi Carrera y Rafel Bru se utilizarán para avanzar en el desarrollo de su plataforma de reconocimiento de la sepsis. @tinofernandez @exp_startup expansion.com/expansion-empl…
Español
ALTA LIFE SCIENCES retweetledi
DeepUll consigue 13 millones para avanzar en el diagnóstico de la sepsis dozz.es/mah0q2
Español
ALTA LIFE SCIENCES retweetledi
#PCBCommunity | #DeepUll, based in #PCB_UB, raises €13M Series B financing to progress its first-in-class early #sepsis recognition platform towards the market
@CDTI_innovacion @CienciaGob @ICOgob @_AltaLS @KurmaPartners @ui_invest #MedicalDiagnostics
pcb.ub.edu/en/deepull-rai…
English
ALTA LIFE SCIENCES retweetledi
binx health announced today the appointment of Todd Bennett as CCO. Todd is an accomplished industry veteran, having held multiple executive leadership roles at several high-growth diagnostic and healthcare technology companies. Read more here: bwnews.pr/3COHouI
GIF
English
ALTA LIFE SCIENCES retweetledi
binx health brings convenient access to high-quality reference laboratory-based testing with the potential to drive better outcomes. Learn more about how we can service your organization or community: #contact" target="_blank" rel="nofollow noopener">mybinxhealth.com/about-us#conta… #COVID19 #STItesting
GIF
English
ALTA LIFE SCIENCES retweetledi
We are pleased to announce that we have signed an exclusive worldwide licensing agreement with Oculis to develop and commercialize a potentially disease modifying therapy to protect and prevent damage to the optic nerve and retina. #glaucoma #opticneuritis
accure.health/oculis-strengt…
English
Happy to announce that Oculis Strengthens Leading Ophthalmology Pipeline by InLicensing Neuroprotective Drug Candidate for Glaucoma from @AccureTherapeut
altals.com/blog/2022/03/0…
English
ALTA LIFE SCIENCES retweetledi
MYC inhibition halts metastatic breast cancer progression by blocking tumor growth, invasion & seeding. Congratulations @peptomyc Team and @VHIO! @LauraSoucek & Daniel Massó-Vallés!
Vall d’Hebron Institute of Oncology (VHIO)@VHIO
🗞 Published in @CRC_AACR, a study led by VHIO’s @LauraSoucek, first-authored by Daniel Massó-Vallés at VHIO spin-off @peptomyc, shows that MYC inhibition by Omomyc halts disease progression in metastatic breast cancer. ➕ bit.ly/VHIO-OmomycBre…
English
ALTA LIFE SCIENCES retweetledi
#JustPublished! MYC inhibition is anti-metastatic in #BreastCancer by Massó-Vallés, @LauraSoucek et al.
bit.ly/3tfYP3l
@peptomyc @VHIO #openaccess
Català
ALTA LIFE SCIENCES retweetledi
"Parar la proteína 'myc' significa parar el crecimiento de tumores humanos"
En el #Canal24Horas han hablado con Laura Soucek, jefa del grupo del Instituto de Oncología Vall d'Hebron (@VHIO)
#Echobox=1645472299" target="_blank" rel="nofollow noopener">rtve.es/play/videos/la…
Español
ALTA LIFE SCIENCES retweetledi
"𝑈𝑛 𝑓𝑎̀𝑟𝑚𝑎𝑐 𝑟𝑒𝑣𝑜𝑙𝑢𝑐𝑖𝑜𝑛𝑎𝑟𝑖 𝑞𝑢𝑒 𝑒𝑙𝑖𝑚𝑖𝑛𝑎 𝑐𝑒̀𝑙·𝑙𝑢𝑙𝑒𝑠 𝑐𝑎𝑛𝑐𝑒𝑟𝑜𝑠𝑒𝑠"
@LauraSoucek, CEO de @peptomyc, fue entrevistada ayer en el programa REVOLUCIÓ 4.0 de @CatalunyaRadio
cutt.ly/cOKeyA2
Català
ALTA LIFE SCIENCES retweetledi
Peptomyc is hiring! We are looking for a Clinical distribution and Logistics manager.
More info here: bit.ly/3onOh06
If you are interested in this offer please send your CV to info@peptomyc.com
English
ALTA LIFE SCIENCES retweetledi
Con motivo del día ᴅɪ́ᴀ Iɴᴛᴇʀɴᴀᴄɪᴏ́ɴᴀʟ ᴅᴇ ʟᴀ Eᴅᴜᴄᴀᴄɪᴏ́ɴ, @BusinessInsider entrevista a 61 empresarios, inversores, directivos e investigadores; comentan qué echaron en falta y qué cambiarían de su época en las aulas.
bit.ly/3ICgJTX @LauraSoucek
Business Insider España@BIEspana
🎓 @LauraSoucek, profesora de investigación en ICREA y fundadora de @Peptomyc: "En mi caso, me hubiera gustado tener más información sobre las posibilidades de intercambio entre la carrera académica y el sector privado en el que iba a trabajar después de graduarme".
Español
ALTA LIFE SCIENCES retweetledi
ALTA LIFE SCIENCES retweetledi
#VentureCapital: @peptomyc logra 8,6 millones de sus socios y busca más inversores expansion.com/catalunya/2022… a través de @expansioncom
Español
ALTA LIFE SCIENCES retweetledi
Very happy to welcome Dr Michel Detheux as Independent Chair to ONA’s board of directors. linkedin.com/posts/ona-ther…
English
ALTA LIFE SCIENCES retweetledi
I am thrilled to welcome Dr Michel Detheux as Independent Chair of ONA’s board of directors.
Ona Therapeutics@OnaTherapeutics
Very happy to welcome Dr Michel Detheux as Independent Chair to ONA’s board of directors. linkedin.com/posts/ona-ther…
English
ALTA LIFE SCIENCES retweetledi
Enhorabuena a @SanifitLabs por este broche de oro a estos 17 años de compromiso y esfuerzo. Mérito de @perellojoan y todo el equipo, gracias a la apuesta de @CaixaCR @YsiosCapital @_AltaLS @InvivoCapital e #innvierte de @CDTIoficial
sanifit.com/vifor-pharma-t…
Español
ALTA LIFE SCIENCES retweetledi
#VentureCapital: @ViforPharmaES adquirirá @SanifitLabs, participada por @YsiosCapital, @CaixaCR, @_AltaLS, ColumbusVP, Healthequity y el @CDTIoficial bit.ly/3cz4RnF
Español